Exagen Inc. XGN Reportable Segment — Net loss
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s reportable segment — net loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s reportable segment — net loss?
- Exagen Inc. (XGN) reported reportable segment — net loss of -$3.97M in Q1 2026.
- How has Exagen Inc.'s reportable segment — net loss changed year-over-year?
- Exagen Inc.'s reportable segment — net loss decreased by 5.7% year-over-year, from -$3.75M to -$3.97M.
- What is the long-term trend for Exagen Inc.'s reportable segment — net loss?
- Over 2 years (2023 to 2025), Exagen Inc.'s reportable segment — net loss has grown at a -8.2% compound annual growth rate (CAGR), from -$23.69M to -$19.95M.
- What does reportable segment — net loss mean?
- The final bottom-line financial result for the reportable segment after all operating expenses, non-operating items, and income taxes have been accounted for. A negative value indicates that the segment is currently operating at a loss. This is the ultimate measure of the segment's financial performance for the period.